Hirotaka Suto1,2, Makiko Suto3, Yumiko Inui2, Atsuo Okamura2. 1. Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan; hirotaka.suto@jfcr.or.jp. 2. Department of Medical Oncology/Hematology, Kakogawa Central City Hospital, Hyogo, Japan. 3. Department of Cardiovascular Medicine, Takarazuka City Hospital, Hyogo, Japan.
Abstract
BACKGROUND/AIM: Pulmonary arterial intimal sarcoma (PAIS) is a rare malignant soft tissue tumor that is difficult to differentiate from pulmonary thromboembolism (PTE). Therefore, pre-operative diagnosis is often difficult. However, recent advances in fluorodeoxyglucose positron emission tomography (FDG-PET) have enabled the use of standardized uptake values (SUVs) for the differential diagnosis of PAIS from PTE, and the frequency of diagnosis of PAIS has increased. Here, we report a case of PAIS that was difficult to differentiate from PTE despite using FDG-PET. CASE REPORT: A 40-year-old woman presented with gradually worsening exertional dyspnea. Contrast-enhanced computed tomography (CT) revealed lesions with poor enhancement in the right lateral basal pulmonary artery. FDG-PET/CT did not reveal any tumor or thrombosis in other areas. Cytological evaluation using a right ventricular catheter did not lead to a definitive diagnosis. Because the patient did not respond to anticoagulation, we performed pulmonary artery endarterectomy. Pathological examination of the pulmonary artery tumor revealed a mucinous tumor with an edematous stroma and spindle-shaped tumor-cell proliferation, which confirmed the diagnosis of PAIS. However, FDG/PET demonstrated a low SUV of 3.4. CONCLUSION: Some PAISs with low cellular densities and high mucous tissue proportions have SUVs similar to those in PTE. In patients with low FDG uptake, if PAIS is suspected based on other objective findings, additional exploration using highly invasive tests or surgical procedures specific to PAIS is warranted.
BACKGROUND/AIM: Pulmonary arterial intimal sarcoma (PAIS) is a rare malignant soft tissue tumor that is difficult to differentiate from pulmonary thromboembolism (PTE). Therefore, pre-operative diagnosis is often difficult. However, recent advances in fluorodeoxyglucose positron emission tomography (FDG-PET) have enabled the use of standardized uptake values (SUVs) for the differential diagnosis of PAIS from PTE, and the frequency of diagnosis of PAIS has increased. Here, we report a case of PAIS that was difficult to differentiate from PTE despite using FDG-PET. CASE REPORT: A 40-year-old woman presented with gradually worsening exertional dyspnea. Contrast-enhanced computed tomography (CT) revealed lesions with poor enhancement in the right lateral basal pulmonary artery. FDG-PET/CT did not reveal any tumor or thrombosis in other areas. Cytological evaluation using a right ventricular catheter did not lead to a definitive diagnosis. Because the patient did not respond to anticoagulation, we performed pulmonary artery endarterectomy. Pathological examination of the pulmonary artery tumor revealed a mucinous tumor with an edematous stroma and spindle-shaped tumor-cell proliferation, which confirmed the diagnosis of PAIS. However, FDG/PET demonstrated a low SUV of 3.4. CONCLUSION: Some PAISs with low cellular densities and high mucous tissue proportions have SUVs similar to those in PTE. In patients with low FDG uptake, if PAIS is suspected based on other objective findings, additional exploration using highly invasive tests or surgical procedures specific to PAIS is warranted.
Authors: Robert R Flavell; David M Naeger; Carina Mari Aparici; Randall A Hawkins; Miguel H Pampaloni; Spencer C Behr Journal: Radiographics Date: 2016 Jan-Feb Impact factor: 5.333
Authors: Agnès Neuville; Françoise Collin; Patrick Bruneval; Marie Parrens; Françoise Thivolet; Anne Gomez-Brouchet; Philippe Terrier; Vincent Thomas de Montpreville; François Le Gall; Isabelle Hostein; Pauline Lagarde; Frédéric Chibon; Jean-Michel Coindre Journal: Am J Surg Pathol Date: 2014-04 Impact factor: 6.394
Authors: Kambiz Rahbar; Harald Seifarth; Michael Schäfers; Lars Stegger; Andreas Hoffmeier; Tilmann Spieker; Klaus Tiemann; David Maintz; Hans Heinrich Scheld; Otmar Schober; Matthias Weckesser Journal: J Nucl Med Date: 2012-05-10 Impact factor: 10.057
Authors: Christian von Falck; Bernhard Meyer; Christine Fegbeutel; Florian Länger; Frank Bengel; Frank Wacker; Thomas Rodt Journal: BMC Med Imaging Date: 2013-08-07 Impact factor: 1.930
Authors: Han Hsi Wong; Ioannis Gounaris; Ann McCormack; Marius Berman; Dochka Davidson; Gail Horan; Joanna Pepke-Zaba; David Jenkins; Helena M Earl; Helen M Hatcher Journal: Clin Sarcoma Res Date: 2015-01-21